Remote ischemic preconditioning in percutaneous coronary revascularization: A double-blind randomized controlled clinical trial

Asian Cardiovascular and Thoracic Annals

Volumn 20, Issue 5, 2012, Pages 548-554

  Ghaemian, Ali ^a   Nouraei, S Mahmoud ^a   Abdollahian, Fatemeh ^a   Naghshvar, Farshad ^a   Giussani, Dino A ^b   Nouraei, S A Reza ^b,c  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Angioplasty; Balloon; Coronary; Coronary artery disease; Ischemic preconditioning; Troponin T

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TROPONIN T; BIOLOGICAL MARKER;

ADULT; ANGIOPLASTY; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTIVE SURGERY; FEMALE; FOLLOW UP; HEART DEATH; HEART MUSCLE INJURY; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; ISCHEMIC PRECONDITIONING; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL DISEASE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PEROPERATIVE COMPLICATION; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT; THORAX PAIN; AGED; ANGINA PECTORIS; BLOOD; BLOOD FLOW; CHI SQUARE DISTRIBUTION; CONTROLLED CLINICAL TRIAL; DRUG ELUTING STENT; HEART MUSCLE ISCHEMIA; INSTRUMENTATION; IRAN; LEG; METHODOLOGY; MIDDLE AGED; REPERFUSION INJURY; RISK FACTOR; STATISTICAL MODEL; TIME; TOURNIQUET; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; VASCULARIZATION;

AGED; ANGINA PECTORIS; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; DRUG-ELUTING STENTS; FEMALE; HUMANS; IRAN; ISCHEMIC PRECONDITIONING; LOGISTIC MODELS; LOWER EXTREMITY; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; REGIONAL BLOOD FLOW; RISK FACTORS; TIME FACTORS; TOURNIQUETS; TREATMENT OUTCOME; TROPONIN T;

EID: 84875870947     PISSN: 02184923     EISSN: 18165370     Source Type: Journal    
DOI: 10.1177/0218492312439999     Document Type: Article

References (16)

1. Nienhuis MB, Ottervanger JP, Bilo HJ, Dikkeschei BD and Zijlstra F. Prognostic value of troponin after elective percutaneous coronary intervention: a meta-analysis. Catheter Cardiovasc Interv 2008; 71: 318-324.
2. Levitsky S. Protecting the myocardial cell during coronary revascularization. The William W. L. Glenn Lecture. Circulation 2006; 114(Suppl I): 339-343.
3. Hausenloy DJ and Yellon DM. Preconditioning and postconditioning: underlying mechanisms and clinical application [Review]. Atherosclerosis 2009; 204: 334-341.
4. Kharbanda RK, Nielsen TT and Redington AN. Translation of remote ischaemic preconditioning into clinical practice [Review]. Lancet 2009; 374: 1557-1565.
5. Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J, et al. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol 2006; 47: 2277-2282.
6. Takagi H, Manabe H, Kawai N, Goto SN and Umemoto T. Review and meta-analysis of randomized controlled clinical trials of remote ischemic preconditioning in cardiovascular surgery [Review]. Am J Cardiol 2008; 102: 1487-1488.
7. Walsh SR, Tang TY, Sadat U and Gaunt ME. Remote ischemic preconditioning in major vascular surgery [Review]. J Vasc Surg 2009; 49: 240-243.
8. Hoole SP, Heck PM, Sharples L, Khan SN, Duehmke R, Densem CG, et al. Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: a prospective, randomized control trial. Circulation 2009; 119: 820-827.
9. Cleveland JC, Meldrum DR, Cain BS, Banerjee A and Harken AH. Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited. Circulation 1997; 96: 29-32.
10. Loubani M and Galiñanes M. Long-term administration of nicorandil abolishes ischemic and pharmacologic preconditioning of the human myocardium: role of mitochondrial adenosine triphosphate-dependent potassium channels. J Thorac Cardiovasc Surg 2002; 124: 750-757.
11. Hall WH, Ramachandran R, Narayan S, Jani AB and Vijayakumar S. An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer 2004; 4: 94.
12. Woodward M, Brindle P and Tunstall-Pedoe H; SIGN group on risk estimation. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart 2007; 93: 172-176.
13. Graham MM, Faris PD, Ghali WA, Galbraith PD, Norris CM, Badry JT, et al. Validation of three myocardial jeopardy scores in a population-based cardiac catheterization cohort. Am Heart J 2001; 141: 254-261.
14. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: implications for patient selection: Multivessel Angioplasty Prognosis Study Group. Circulation 1990; 82: 1193-1202.
15. Ali ZA, Callaghan CJ, Lim E, Ali AA, Nouraei SA, Akthar AM, et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation 2007; 116(Suppl I): 98-105.
16. Porto I, Blackman DJ, Nicolson D, Niccoli G, Kahn FZ, Ormerod O, et al. What is the incidence of myocardial necrosis in elective patients discharged on the same day following percutaneous coronary intervention? Heart 2004; 90: 1489-1490.